Nanoscale engineering and Mo-doping of 2D ultrathin ReS2 nanosheets for remarkable electrocatalytic hydrogen generation.

Two-dimensional (2D) lamellar ReS2 nanosheets are considered a promising electrocatalyst for the hydrogen evolution reaction (HER) but suffer from poor intrinsic conductivity and catalytically inert basal planes. In this work, sub 50 nm hierarchical Mo-doped ReS2 nanospheres consisting of numerous few-layered and defect-rich nanosheets are designed and synthesized as robust and efficient HER catalysts. On the one hand, the small size of the hierarchical structure, the disordered basal planes and the expanded interlayer endow the nanosheets with plentiful defects, thereby resulting in abundant exposed active sites. On the other hand, Mo-doping offers the nanosheets with some electronic benefits of unsaturated electrons, improved intrinsic conductivity, and optimized hydrogen adsorption free energy (ΔGH) of the basal planes. Owing to the synergistic effects, the 10%Mo-ReS2 catalyst exhibits an optimized catalytic activity with striking kinetic metrics of a small Tafel slope of 62 mV dec-1, a low overpotential of 81 mV at 10 mA cm-2, and a long operation stability of 50 h, and its performance is among the best of ReS2-based catalysts. This work provides a new approach for gaining the structural and electronic benefits of ReS2 catalysts by combinational nanoscale engineering and heteroatom doping.

Huachansu suppresses TRPV1 up-regulation and spinal astrocyte activation to prevent oxaliplatin-induced peripheral neuropathic pain in rats.

Chemotherapy-induced peripheral neuropathic pain (CIPNP) is a major dose- and therapy-limiting side effect that is particularly difficult to treat. Huachansu, an aqueous extract from toad skin, is a widely used anti-cancer natural product in China. Clinical findings have established the safety and effectiveness of Huachansu in combination with chemotherapy to promote the therapeutic efficacy while alleviate the side effects, especially cancer-related pain symptoms. Unfortunately, experimental data on the effects and mechanisms of Huachansu in combination with chemotherapy is not available. In this study, the effects of Huachansu were tested in vivo on a rat model of oxaliplatin-induced CIPNP. The results show, a single injection of Huachansu 2.5 g/kg produced a short-term analgesic effect on pre-established oxaliplatin-induced CIPNP after 60 min, as indicated by decreased mechanical and thermal hypersensitivity in comparison to oxaliplatin-treated rats. Repeated doses of Huachansu, given during CIPNP induction, prevented the development of oxaliplatin-induced CIPNP. This prophylactic effect of Huachansu was associated with suppressed oxaliplatin-induced TRPV1 up-regulation in the dorsal root ganglia and spinal astrocyte activation. These findings reveal Huachansu therapeutic potential in treating and preventing CIPNP.